A pooled analysis evaluated reductions in migraine and headache days among patients with chronic migraine and comorbid depression in 2 placebo-controlled, phase 3 trials of fremanezumab.
Fibromyalgia is a chronic pain condition characterized by widespread musculoskeletal pain, sleep disturbance, fatigue.
Recommendations for addressing mental health among pain management fellows during the COVID-19 pandemic.
Depression is twice as common in patients with chronic pain compared to health subjects, and pain intensity, frequency, and number of locations are linked to depression and anxiety.
Compared with people without migraine, people with migraine and migraine with medication overuse headache often have deficits in metacognition.
Researchers found that overall research design and methodological criteria need to be examined closely to gauge true treatment effects in chronic pain clinical trials.
Patients with new-onset low back pain who initially consulted a chiropractor or physical therapist vs a primary care physician were found to have reduced risk for long-term opioid use.
Patients on long-term opioid treatment for chronic pain reported experiencing negative physical side effects, emotional distress, and degraded relationships with their primary care provider.
There are a number of challenges associated with the use of cannabidiol and hemp oils in pain management.
Researchers are developing a consensus report to provide clinical guidance for the management of patients with chronic non cancer pain who are taking both opioids and cannabinoids.
